MedPath

Supplements for Controlling Resistance to Insulin

Phase 4
Terminated
Conditions
Diabetes Mellitus, Type 2
Obesity
Interventions
Drug: nutrition education plus active supplement
Drug: nutrition education plus inactive supplement
Registration Number
NCT00699413
Lead Sponsor
University of Southern California
Brief Summary

The purpose of this study is to evaluate the effects of a combination of hydroxcycitrate (HCA) and niacin-bound chromium, in conjunction with nutrition education, over a twelve week period. Participants will be evaluated with regard to BMI, percent body fat, insulin activity, and hunger.

Detailed Description

The prevalence of obesity among youth has increased dramatically in recent years. Parallel to the increased rates of pediatric obesity, overweight children present clinically with adiposity related comorbidities such as insulin resistance and type 2 diabetes. The prevailing recommendations for overweight youth are to increase physical activity levels and limit energy intake in order to improve body composition. Currently there is little empirical evidence to support the efficacy of these recommendations. Alternatively, evidence in adults suggests that nutritional supplementation with (-) hydroxycitric acid (HCA), an organic acid found naturally in citrus fruits, and chromium may lead to favorable changes in body composition and improve glucose regulation. To date, these issues have not been tested in youth. Therefore, the purpose of the present investigation is to examine the effects of a nutritional education program combined with either HCA + chromium or placebo on measures of body composition and glucose regulation in overweight adolescents.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Age

    • All subjects will be between 13 and 17 years of age
  • Overweight

    • All subjects will be overweight as defined by an age & sex-specific body mass index ≥ 85th percentile based on CDC BMI growth charts [US Department of Health and Human Services, 2000], calculated by Epi Info Software, version 3.3.
Exclusion Criteria
  • Presently taking any prescribed medication(s) or diagnosed with any syndrome or disease that could influence dietary intake, body composition and fat distribution, or insulin action or secretion.
  • Previously diagnosed with any major illness since birth (e.g. sever intrauterine growth retardation, chronic birth asphyxia, cancer).
  • Children with type 1 and/or type 2 diabetes will be excluded are referred to a physician.
  • Currently involved with any dietary, exercise, or weight loss program or have been in the 6 months prior to participation.
  • Unexplained weight loss or gain in the prior six months.
  • Oral contraception use in sexually active females
  • Children who live further than 20 miles away from the USC Health Science Campus (HSC).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1 - nutrition education plus active supplementnutrition education plus active supplementnutrition education plus active supplement
2 - nutrition education plus inactive supplementnutrition education plus inactive supplementnutrition education plus inactive supplement
Primary Outcome Measures
NameTimeMethod
Body Mass Indexmeasured at baseline and 12 weeks

Change in Body Mass Index measurement at baseline and 12 weeks

Secondary Outcome Measures
NameTimeMethod
Insulin ActivityMeasured at baseline and 12 weeks

Change in insulin activity measured at baseline and 12 weeks

Percent Body FatMeasured at baseline and 12 weeks

Change in percent body fat measured at baseline and 12 weeks

HungerMeasured at baseline and 12 weeks

Change in hunger score using Likert scale measured at baseline and 12 weeks

Trial Locations

Locations (1)

USC - Preventive Medicine

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath